R

Rapport Therapeutics

Develops precision neuromedicines for brain disorders

Associate Director - Medical Writing

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeBoston, MA, USA$185k - $205k /yr

About the Job

Requirements

  • A minimum of 8+ years of relevant medical writing experience in the biopharmaceutical industry, with proven success leading the preparation of clinical and regulatory documentation.
  • An advanced degree in a scientific or health-related discipline is preferred; an equivalent combination of education and relevant regulatory medical writing experience may be considered.
  • Experience as a lead writer for late-phase clinical programs is required; central nervous system experience is strongly preferred.
  • Thorough understanding of International Council for Harmonisation, Food and Drug Administration, and European Medicines Agency regulatory requirements for clinical and regulatory documents.
  • Demonstrated artificial intelligence literacy and practical experience using, evaluating, or implementing artificial intelligence-enabled tools, automation, structured content, content reuse, or other technologies to improve medical writing efficiency, consistency, and quality.
  • Strong judgment in the responsible use of artificial intelligence, including the ability to validate artificial intelligence-assisted outputs, identify risks and limitations, maintain data confidentiality, and ensure that final deliverables meet scientific, regulatory, and quality standards.
  • Strong written and verbal communication skills, attention to detail, and the ability to manage multiple priorities.
  • Strong stakeholder management skills, including the ability to build trust with cross-functional partners, navigate ambiguity, manage competing priorities and perspectives, resolve disputes constructively, and foster alignment among diverse contributors.
  • Demonstrated leadership, project management, stakeholder management, and mentoring skills, with the ability to influence without authority and maintain momentum in complex, cross-functional document development processes.

Responsibilities

  • Lead the development, writing, and review of key clinical and regulatory documents for the RAP-219 program, including clinical study protocols, clinical study reports, Investigator’s Brochures, briefing documents, and Module 2 summaries.
  • Collaborate with medical science, clinical operations, regulatory, biostatistics, pharmacovigilance, and other functions to ensure accurate, consistent, and strategically aligned document content; manage stakeholder input, reconcile differing perspectives, and drive timely resolution of conflicting feedback.
  • Provide strategic input and guidance on document content, structure, and timelines to support regulatory submissions and global health authority interactions.
  • Maintain up-to-date knowledge of regulatory medical writing standards, relevant regulatory guidelines, and advances in artificial intelligence, automation, structured content, and digital technologies affecting regulatory documentation.
  • Evaluate and support implementation of artificial intelligence-enabled tools and automation solutions to improve document development, quality control, content reuse, and workflow efficiency; assess benefits and limitations and help establish standards for compliant adoption.
  • Contribute to the development, modernization, and implementation of medical writing processes, templates, standards, and tools, with a focus on scalable approaches that improve quality, consistency, and operational efficiency.

Desired Qualifications

  • Central nervous system experience.
  • An advanced degree in a scientific or health-related discipline.

About the Company

Rapport Therapeutics

Develops precision neuromedicines for brain disorders

Rapport Therapeutics develops precision neuromedicines for neurological disorders. The company focuses on discovering and developing drugs that act only in disease-relevant areas of the brain to reduce symptoms with fewer side effects. Their discovery platform uses region-specific RAPs (Receptor Associated Proteins) to guide drug targeting to specific brain cells or regions, aiming to improve patient benefit. Unlike many peers, Rapport emphasizes selective targeting through RAPs and relies on experienced leadership to drive science and partnerships, with revenue from developing and potentially running clinical trials and related services. The goal is to provide treatments for drug-resistant epilepsies and mood disorders by delivering therapies that are active only where needed in the brain, reducing unwanted effects and improving outcomes.

Company size
51-200
Company stage
IPO
Headquarters
Boston, MA
Founded
2022

Recently Posted Jobs

Explore more opportunities at Rapport Therapeutics

See more jobs